Zepsyre

Zepsyre has a path to market at last
EP Vantage
Mon, 08/19/19 - 10:55 am
PharmaMar
FDA
Zepsyre
small cell lung cancer
PharmaMar stock tanks after PhIII ovarian cancer study flops
Endpoints
Sat, 01/20/18 - 02:53 pm
PharmaMar
ovarian cancer
clinical trials
Zepsyre